Survival benefits of interferon-based therapy in patients with recurrent hepatitis C after orthotopic liver transplantation
Recurrent hepatitis C after orthotopic liver transplantation (OLT) is universal and can lead to graft failure and, consequently, reduced survival. Hepatitis C treatment can be used to prevent these detrimental outcomes. The aim of this study was to describe rates of hepatitis C recurrence and sustai...
Main Authors: | L.P. Zanaga, A.G. Vigani, R.N. Angerami, A. Giorgetti, C.A.F. Escanhoela, E.C. Ataíde, I.F.S.F. Boin, R.S.B. Stucchi |
---|---|
Format: | Article |
Language: | English |
Published: |
Associação Brasileira de Divulgação Científica
|
Series: | Brazilian Journal of Medical and Biological Research |
Subjects: | |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2017000100701&lng=en&tlng=en |
Similar Items
-
Recurrent hepatitis C treatment with direct acting antivirals – a real life study at a Brazilian liver transplant center
by: L.P. Zanaga, et al. -
Induction with Rabbit Antithymocyte Globulin following Orthotopic Liver Transplantation for Hepatitis C
by: R. F. Saidi, et al.
Published: (2011-10-01) -
Treatment of hepatitis C virus genotype 3 infection with direct-acting antiviral agents
by: L.P. Zanaga, et al. -
Diagnosis and staging of fibrosis in patients with chronic hepatitis C: comparison and critical overview of current strategies
by: Mendes LC, et al.
Published: (2018-04-01) -
Experience of effective antiviral therapy in a liver recipient with recurrent HCV infection genotype 1
by: D. V. Umrik, et al.
Published: (2019-01-01)